시장조사 보고서 : 세계의 파클리탁셀 주사 시장예측 2021년-2026년

■ 영문 제목 : Global Paclitaxel Injection Market Growth 2021-2026
	■ 상품코드 : LPI-2201K02130 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 102 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 파클리탁셀 주사의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (5ml,30mg, 10ml,60mg, 16.7ml,100mg, 25ml,150mg, 50ml,300mg)와 용도별 시장규모 (난소암, 유방암, 자궁 경부암, 췌장암, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 파클리탁셀 주사 시장 점유율
- 지역별 파클리탁셀 주사 시장규모
- 주요지역의 종류별 시장규모 (5ml,30mg, 10ml,60mg, 16.7ml,100mg, 25ml,150mg, 50ml,300mg)
- 주요지역의 용도별 시장규모 (난소암, 유방암, 자궁 경부암, 췌장암, 기타)
- 미주의 파클리탁셀 주사 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 파클리탁셀 주사 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 파클리탁셀 주사 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 파클리탁셀 주사 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 파클리탁셀 주사 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Bristol-Myers Squibb, Celgene Corporation, Hospira, Biological E., Taj Accura, Khandelwal Laboratories, Luye Pharma, Beijing Youcare, Beijing Union, Haiyao, Chuntch
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Paclitaxel Injection will have significant change from previous year. By the most conservative estimates of global Paclitaxel Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 2979.7 million in 2020. Over the next five years the Paclitaxel Injection market will register a 11.5% CAGR in terms of revenue, the global market size will reach US$ 4608 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Paclitaxel Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
5ml,30mg
10ml,60mg
16.7ml,100mg
25ml,150mg
50ml,300mg

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Ovarian Cancer
Breast Cancer
Cervical Cancer
Pancreatic Cancer
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Bristol-Myers Squibb
Celgene Corporation
Hospira
Biological E.
Taj Accura
Khandelwal Laboratories
Luye Pharma
Beijing Youcare
Beijing Union
Haiyao
Chuntch

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Paclitaxel Injection Consumption 2016-2026
2.1.2 Paclitaxel Injection Consumption CAGR by Region
2.2 Paclitaxel Injection Segment by Type
2.2.1 5ml,30mg
2.2.2 10ml,60mg
2.2.3 16.7ml,100mg
2.2.4 25ml,150mg
2.2.5 50ml,300mg
2.3 Paclitaxel Injection Sales by Type
2.3.1 Global Paclitaxel Injection Sales Market Share by Type (2016-2021)
2.3.2 Global Paclitaxel Injection Revenue and Market Share by Type (2016-2021)
2.3.3 Global Paclitaxel Injection Sale Price by Type (2016-2021)
2.4 Paclitaxel Injection Segment by Application
2.4.1 Ovarian Cancer
2.4.2 Breast Cancer
2.4.3 Cervical Cancer
2.4.4 Pancreatic Cancer
2.4.5 Other
2.5 Paclitaxel Injection Sales by Application
2.5.1 Global Paclitaxel Injection Sale Market Share by Application (2016-2021)
2.5.2 Global Paclitaxel Injection Revenue and Market Share by Application (2016-2021)
2.5.3 Global Paclitaxel Injection Sale Price by Application (2016-2021)

3 Global Paclitaxel Injection by Company
3.1 Global Paclitaxel Injection Sales Market Share by Company
3.1.1 Global Paclitaxel Injection Sales by Company (2019-2021)
3.1.2 Global Paclitaxel Injection Sales Market Share by Company (2019-2021)
3.2 Global Paclitaxel Injection Revenue Market Share by Company
3.2.1 Global Paclitaxel Injection Revenue by Company (2019-2021)
3.2.2 Global Paclitaxel Injection Revenue Market Share by Company (2019-2021)
3.3 Global Paclitaxel Injection Sale Price by Company
3.4 Global Manufacturers Paclitaxel Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Paclitaxel Injection Product Location Distribution
3.4.2 Players Paclitaxel Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Paclitaxel Injection by Region
4.1 Global Paclitaxel Injection by Region
4.1.1 Global Paclitaxel Injection Sales by Region
4.1.2 Global Paclitaxel Injection Revenue by Region
4.2 Americas Paclitaxel Injection Sales Growth
4.3 APAC Paclitaxel Injection Sales Growth
4.4 Europe Paclitaxel Injection Sales Growth
4.5 Middle East & Africa Paclitaxel Injection Sales Growth

5 Americas
5.1 Americas Paclitaxel Injection Sales by Country
5.1.1 Americas Paclitaxel Injection Sales by Country (2016-2021)
5.1.2 Americas Paclitaxel Injection Revenue by Country (2016-2021)
5.2 Americas Paclitaxel Injection Sales by Type
5.3 Americas Paclitaxel Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Paclitaxel Injection Sales by Region
6.1.1 APAC Paclitaxel Injection Sales by Region (2016-2021)
6.1.2 APAC Paclitaxel Injection Revenue by Region (2016-2021)
6.2 APAC Paclitaxel Injection Sales by Type
6.3 APAC Paclitaxel Injection Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Paclitaxel Injection by Country
7.1.1 Europe Paclitaxel Injection Sales by Country (2016-2021)
7.1.2 Europe Paclitaxel Injection Revenue by Country (2016-2021)
7.2 Europe Paclitaxel Injection Sales by Type
7.3 Europe Paclitaxel Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Paclitaxel Injection by Country
8.1.1 Middle East & Africa Paclitaxel Injection Sales by Country (2016-2021)
8.1.2 Middle East & Africa Paclitaxel Injection Revenue by Country (2016-2021)
8.2 Middle East & Africa Paclitaxel Injection Sales by Type
8.3 Middle East & Africa Paclitaxel Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Paclitaxel Injection Distributors
10.3 Paclitaxel Injection Customer

11 Global Paclitaxel Injection Market Forecast
11.1 Global Paclitaxel Injection Forecast by Region
11.1.1 Global Paclitaxel Injection Forecast by Regions (2021-2026)
11.2.2 Global Paclitaxel Injection Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Paclitaxel Injection Forecast by Type
11.7 Global Paclitaxel Injection Forecast by Application

12 Key Players Analysis
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Company Information
12.1.2 Bristol-Myers Squibb Paclitaxel Injection Product Offered
12.1.3 Bristol-Myers Squibb Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Bristol-Myers Squibb Main Business Overview
12.1.5 Bristol-Myers Squibb Latest Developments
12.2 Celgene Corporation
12.2.1 Celgene Corporation Company Information
12.2.2 Celgene Corporation Paclitaxel Injection Product Offered
12.2.3 Celgene Corporation Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Celgene Corporation Main Business Overview
12.2.5 Celgene Corporation Latest Developments
12.3 Hospira
12.3.1 Hospira Company Information
12.3.2 Hospira Paclitaxel Injection Product Offered
12.3.3 Hospira Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Hospira Main Business Overview
12.3.5 Hospira Latest Developments
12.4 Biological E.
12.4.1 Biological E. Company Information
12.4.2 Biological E. Paclitaxel Injection Product Offered
12.4.3 Biological E. Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Biological E. Main Business Overview
12.4.5 Biological E. Latest Developments
12.5 Taj Accura
12.5.1 Taj Accura Company Information
12.5.2 Taj Accura Paclitaxel Injection Product Offered
12.5.3 Taj Accura Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Taj Accura Main Business Overview
12.5.5 Taj Accura Latest Developments
12.6 Khandelwal Laboratories
12.6.1 Khandelwal Laboratories Company Information
12.6.2 Khandelwal Laboratories Paclitaxel Injection Product Offered
12.6.3 Khandelwal Laboratories Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Khandelwal Laboratories Main Business Overview
12.6.5 Khandelwal Laboratories Latest Developments
12.7 Luye Pharma
12.7.1 Luye Pharma Company Information
12.7.2 Luye Pharma Paclitaxel Injection Product Offered
12.7.3 Luye Pharma Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Luye Pharma Main Business Overview
12.7.5 Luye Pharma Latest Developments
12.8 Beijing Youcare
12.8.1 Beijing Youcare Company Information
12.8.2 Beijing Youcare Paclitaxel Injection Product Offered
12.8.3 Beijing Youcare Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Beijing Youcare Main Business Overview
12.8.5 Beijing Youcare Latest Developments
12.9 Beijing Union
12.9.1 Beijing Union Company Information
12.9.2 Beijing Union Paclitaxel Injection Product Offered
12.9.3 Beijing Union Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Beijing Union Main Business Overview
12.9.5 Beijing Union Latest Developments
12.10 Haiyao
12.10.1 Haiyao Company Information
12.10.2 Haiyao Paclitaxel Injection Product Offered
12.10.3 Haiyao Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Haiyao Main Business Overview
12.10.5 Haiyao Latest Developments
12.11 Chuntch
12.11.1 Chuntch Company Information
12.11.2 Chuntch Paclitaxel Injection Product Offered
12.11.3 Chuntch Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Chuntch Main Business Overview
12.11.5 Chuntch Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Paclitaxel Injection Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of 5ml,30mg
Table 3. Major Players of 10ml,60mg
Table 4. Major Players of 16.7ml,100mg
Table 5. Major Players of 25ml,150mg
Table 6. Major Players of 50ml,300mg
Table 7. Global Paclitaxel Injection Sales by Type (2016-2021) & (K Units)
Table 8. Global Paclitaxel Injection Sales Market Share by Type (2016-2021)
Table 9. Global Paclitaxel Injection Revenue by Type (2016-2021) & ($ million)
Table 10. Global Paclitaxel Injection Revenue Market Share by Type (2016-2021)
Table 11. Global Paclitaxel Injection Sale Price by Type (2016-2021)
Table 12. Global Paclitaxel Injection Sales by Application (2016-2021) & (K Units)
Table 13. Global Paclitaxel Injection Sales Market Share by Application (2016-2021)
Table 14. Global Paclitaxel Injection Value by Application (2016-2021)
Table 15. Global Paclitaxel Injection Revenue Market Share by Application (2016-2021)
Table 16. Global Paclitaxel Injection Sale Price by Application (2016-2021)
Table 17. Global Paclitaxel Injection Sales by Company (2019-2021) & (K Units)
Table 18. Global Paclitaxel Injection Sales Market Share by Company (2019-2021)
Table 19. Global Paclitaxel Injection Revenue by Company (2019-2021) ($ Millions)
Table 20. Global Paclitaxel Injection Revenue Market Share by Company (2019-2021)
Table 21. Global Paclitaxel Injection Sale Price by Company (2019-2021)
Table 22. Key Manufacturers Paclitaxel Injection Producing Area Distribution and Sales Area
Table 23. Players Paclitaxel Injection Products Offered
Table 24. Paclitaxel Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Paclitaxel Injection Sales by Region (2016-2021) (K Units)
Table 28. Global Paclitaxel Injection Sales Market Share by Region (2016-2021)
Table 29. Global Paclitaxel Injection Revenue by Region (2016-2021) & ($ Millions)
Table 30. Global Paclitaxel Injection Revenue Market Share by Region (2016-2021)
Table 31. Americas Paclitaxel Injection Sales by Country (2016-2021) & (K Units)
Table 32. Americas Paclitaxel Injection Sales Market Share by Country (2016-2021)
Table 33. Americas Paclitaxel Injection Revenue by Country (2016-2021) & ($ Millions)
Table 34. Americas Paclitaxel Injection Revenue Market Share by Country (2016-2021)
Table 35. Americas Paclitaxel Injection Sales by Type (2016-2021) & (K Units)
Table 36. Americas Paclitaxel Injection Sales Market Share by Type (2016-2021)
Table 37. Americas Paclitaxel Injection Sales by Application (2016-2021) & (K Units)
Table 38. Americas Paclitaxel Injection Sales Market Share by Application (2016-2021)
Table 39. APAC Paclitaxel Injection Sales by Region (2016-2021) & (K Units)
Table 40. APAC Paclitaxel Injection Sales Market Share by Region (2016-2021)
Table 41. APAC Paclitaxel Injection Revenue by Region (2016-2021) & ($ Millions)
Table 42. APAC Paclitaxel Injection Revenue Market Share by Region (2016-2021)
Table 43. APAC Paclitaxel Injection Sales by Type (2016-2021) & (K Units)
Table 44. APAC Paclitaxel Injection Sales Market Share by Type (2016-2021)
Table 45. APAC Paclitaxel Injection Sales by Application (2016-2021) & (K Units)
Table 46. APAC Paclitaxel Injection Sales Market Share by Application (2016-2021)
Table 47. Europe Paclitaxel Injection Sales by Country (2016-2021) & (K Units)
Table 48. Europe Paclitaxel Injection Sales Market Share by Country (2016-2021)
Table 49. Europe Paclitaxel Injection Revenue by Country (2016-2021) & ($ Millions)
Table 50. Europe Paclitaxel Injection Revenue Market Share by Country (2016-2021)
Table 51. Europe Paclitaxel Injection Sales by Type (2016-2021) & (K Units)
Table 52. Europe Paclitaxel Injection Sales Market Share by Type (2016-2021)
Table 53. Europe Paclitaxel Injection Sales by Application (2016-2021) & (K Units)
Table 54. Europe Paclitaxel Injection Sales Market Share by Application (2016-2021)
Table 55. Middle East & Africa Paclitaxel Injection Sales by Country (2016-2021) & (K Units)
Table 56. Middle East & Africa Paclitaxel Injection Sales Market Share by Country (2016-2021)
Table 57. Middle East & Africa Paclitaxel Injection Revenue by Country (2016-2021) & ($ Millions)
Table 58. Middle East & Africa Paclitaxel Injection Revenue Market Share by Country (2016-2021)
Table 59. Middle East & Africa Paclitaxel Injection Sales by Type (2016-2021) & (K Units)
Table 60. Middle East & Africa Paclitaxel Injection Sales Market Share by Type (2016-2021)
Table 61. Middle East & Africa Paclitaxel Injection Sales by Application (2016-2021) & (K Units)
Table 62. Middle East & Africa Paclitaxel Injection Sales Market Share by Application (2016-2021)
Table 63. Key and Potential Regions of Paclitaxel Injection
Table 64. Key Application and Potential Industries of Paclitaxel Injection
Table 65. Key Challenges of Paclitaxel Injection
Table 66. Key Trends of Paclitaxel Injection
Table 67. Paclitaxel Injection Distributors List
Table 68. Paclitaxel Injection Customer List
Table 69. Global Paclitaxel Injection Sales Forecast by Region (2021-2026) & (K Units)
Table 70. Global Paclitaxel Injection Consumption Market Forecast by Region
Table 71. Global Paclitaxel Injection Revenue Forecast by Region (2021-2026) & ($ millions)
Table 72. Global Paclitaxel Injection Revenue Market Share Forecast by Region (2021-2026)
Table 73. Americas Paclitaxel Injection Sales Forecast by Country (2021-2026) & (K Units)
Table 74. Americas Paclitaxel Injection Revenue Forecast by Country (2021-2026) & ($ millions)
Table 75. APAC Paclitaxel Injection Sales Forecast by Region (2021-2026) & (K Units)
Table 76. APAC Paclitaxel Injection Revenue Forecast by Region (2021-2026) & ($ millions)
Table 77. Europe Paclitaxel Injection Sales Forecast by Country (2021-2026) & (K Units)
Table 78. Europe Paclitaxel Injection Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Middle East & Africa Paclitaxel Injection Sales Forecast by Country (2021-2026) & (K Units)
Table 80. Middle East & Africa Paclitaxel Injection Revenue Forecast by Country (2021-2026) & ($ millions)
Table 81. Global Paclitaxel Injection Sales Forecast by Type (2021-2026) & (K Units)
Table 82. Global Paclitaxel Injection Sales Market Share Forecast by Type (2021-2026)
Table 83. Global Paclitaxel Injection Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 84. Global Paclitaxel Injection Revenue Market Share Forecast by Type (2021-2026)
Table 85. Global Paclitaxel Injection Sales Forecast by Application (2021-2026) & (K Units)
Table 86. Global Paclitaxel Injection Sales Market Share Forecast by Application (2021-2026)
Table 87. Global Paclitaxel Injection Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 88. Global Paclitaxel Injection Revenue Market Share Forecast by Application (2021-2026)
Table 89. Bristol-Myers Squibb Basic Information, Paclitaxel Injection Manufacturing Base, Sales Area and Its Competitors
Table 90. Bristol-Myers Squibb Paclitaxel Injection Product Offered
Table 91. Bristol-Myers Squibb Paclitaxel Injection Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 92. Bristol-Myers Squibb Main Business
Table 93. Bristol-Myers Squibb Latest Developments
Table 94. Celgene Corporation Basic Information, Paclitaxel Injection Manufacturing Base, Sales Area and Its Competitors
Table 95. Celgene Corporation Paclitaxel Injection Product Offered
Table 96. Celgene Corporation Paclitaxel Injection Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 97. Celgene Corporation Main Business
Table 98. Celgene Corporation Latest Developments
Table 99. Hospira Basic Information, Paclitaxel Injection Manufacturing Base, Sales Area and Its Competitors
Table 100. Hospira Paclitaxel Injection Product Offered
Table 101. Hospira Paclitaxel Injection Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 102. Hospira Main Business
Table 103. Hospira Latest Developments
Table 104. Biological E. Basic Information, Paclitaxel Injection Manufacturing Base, Sales Area and Its Competitors
Table 105. Biological E. Paclitaxel Injection Product Offered
Table 106. Biological E. Paclitaxel Injection Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 107. Biological E. Main Business
Table 108. Biological E. Latest Developments
Table 109. Taj Accura Basic Information, Paclitaxel Injection Manufacturing Base, Sales Area and Its Competitors
Table 110. Taj Accura Paclitaxel Injection Product Offered
Table 111. Taj Accura Paclitaxel Injection Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 112. Taj Accura Main Business
Table 113. Taj Accura Latest Developments
Table 114. Khandelwal Laboratories Basic Information, Paclitaxel Injection Manufacturing Base, Sales Area and Its Competitors
Table 115. Khandelwal Laboratories Paclitaxel Injection Product Offered
Table 116. Khandelwal Laboratories Paclitaxel Injection Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 117. Khandelwal Laboratories Main Business
Table 118. Khandelwal Laboratories Latest Developments
Table 119. Luye Pharma Basic Information, Paclitaxel Injection Manufacturing Base, Sales Area and Its Competitors
Table 120. Luye Pharma Paclitaxel Injection Product Offered
Table 121. Luye Pharma Paclitaxel Injection Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 122. Luye Pharma Main Business
Table 123. Luye Pharma Latest Developments
Table 124. Beijing Youcare Basic Information, Paclitaxel Injection Manufacturing Base, Sales Area and Its Competitors
Table 125. Beijing Youcare Paclitaxel Injection Product Offered
Table 126. Beijing Youcare Paclitaxel Injection Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 127. Beijing Youcare Main Business
Table 128. Beijing Youcare Latest Developments
Table 129. Beijing Union Basic Information, Paclitaxel Injection Manufacturing Base, Sales Area and Its Competitors
Table 130. Beijing Union Paclitaxel Injection Product Offered
Table 131. Beijing Union Paclitaxel Injection Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 132. Beijing Union Main Business
Table 133. Beijing Union Latest Developments
Table 134. Haiyao Basic Information, Paclitaxel Injection Manufacturing Base, Sales Area and Its Competitors
Table 135. Haiyao Paclitaxel Injection Product Offered
Table 136. Haiyao Paclitaxel Injection Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 137. Haiyao Main Business
Table 138. Haiyao Latest Developments
Table 139. Chuntch Basic Information, Paclitaxel Injection Manufacturing Base, Sales Area and Its Competitors
Table 140. Chuntch Paclitaxel Injection Product Offered
Table 141. Chuntch Paclitaxel Injection Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 142. Chuntch Main Business
Table 143. Chuntch Latest Developments
List of Figures
Figure 1. Picture of Paclitaxel Injection
Figure 2. Paclitaxel Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Paclitaxel Injection Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Paclitaxel Injection Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Paclitaxel Injection Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of 5ml,30mg
Figure 10. Product Picture of 10ml,60mg
Figure 11. Product Picture of 16.7ml,100mg
Figure 12. Product Picture of 25ml,150mg
Figure 13. Product Picture of 50ml,300mg
Figure 14. Global Paclitaxel Injection Sales Market Share by Type in 2020
Figure 15. Global Paclitaxel Injection Revenue Market Share by Type (2016-2021)
Figure 16. Paclitaxel Injection Consumed in Ovarian Cancer
Figure 17. Global Paclitaxel Injection Market: Ovarian Cancer (2016-2021) & (K Units)
Figure 18. Paclitaxel Injection Consumed in Breast Cancer
Figure 19. Global Paclitaxel Injection Market: Breast Cancer (2016-2021) & (K Units)
Figure 20. Paclitaxel Injection Consumed in Cervical Cancer
Figure 21. Global Paclitaxel Injection Market: Cervical Cancer (2016-2021) & (K Units)
Figure 22. Paclitaxel Injection Consumed in Pancreatic Cancer
Figure 23. Global Paclitaxel Injection Market: Pancreatic Cancer (2016-2021) & (K Units)
Figure 24. Paclitaxel Injection Consumed in Other
Figure 25. Global Paclitaxel Injection Market: Other (2016-2021) & (K Units)
Figure 26. Global Paclitaxel Injection Sales Market Share by Application (2016-2021)
Figure 27. Global Paclitaxel Injection Revenue Market Share by Application in 2020
Figure 28. Paclitaxel Injection Revenue Market by Company in 2020 ($ Million)
Figure 29. Global Paclitaxel Injection Revenue Market Share by Company in 2020
Figure 30. Global Paclitaxel Injection Sales Market Share by Regions (2016-2021)
Figure 31. Global Paclitaxel Injection Revenue Market Share by Region in 2020
Figure 32. Americas Paclitaxel Injection Sales 2016-2021 (K Units)
Figure 33. Americas Paclitaxel Injection Revenue 2016-2021 ($ Millions)
Figure 34. APAC Paclitaxel Injection Sales 2016-2021 (K Units)
Figure 35. APAC Paclitaxel Injection Revenue 2016-2021 ($ Millions)
Figure 36. Europe Paclitaxel Injection Sales 2016-2021 (K Units)
Figure 37. Europe Paclitaxel Injection Revenue 2016-2021 ($ Millions)
Figure 38. Middle East & Africa Paclitaxel Injection Sales 2016-2021 (K Units)
Figure 39. Middle East & Africa Paclitaxel Injection Revenue 2016-2021 ($ Millions)
Figure 40. Americas Paclitaxel Injection Sales Market Share by Country in 2020
Figure 41. Americas Paclitaxel Injection Revenue Market Share by Country in 2020
Figure 42. Americas Paclitaxel Injection Sales Market Share by Type in 2020
Figure 43. Americas Paclitaxel Injection Sales Market Share by Application in 2020
Figure 44. United States Paclitaxel Injection Revenue Growth 2016-2021 ($ Millions)
Figure 45. Canada Paclitaxel Injection Revenue Growth 2016-2021 ($ Millions)
Figure 46. Mexico Paclitaxel Injection Revenue Growth 2016-2021 ($ Millions)
Figure 47. Brazil Paclitaxel Injection Revenue Growth 2016-2021 ($ Millions)
Figure 48. APAC Paclitaxel Injection Sales Market Share by Region in 2020
Figure 49. APAC Paclitaxel Injection Revenue Market Share by Regions in 2020
Figure 50. APAC Paclitaxel Injection Sales Market Share by Type in 2020
Figure 51. APAC Paclitaxel Injection Sales Market Share by Application in 2020
Figure 52. China Paclitaxel Injection Revenue Growth 2016-2021 ($ Millions)
Figure 53. Japan Paclitaxel Injection Revenue Growth 2016-2021 ($ Millions)
Figure 54. Korea Paclitaxel Injection Revenue Growth 2016-2021 ($ Millions)
Figure 55. Southeast Asia Paclitaxel Injection Revenue Growth 2016-2021 ($ Millions)
Figure 56. India Paclitaxel Injection Revenue Growth 2016-2021 ($ Millions)
Figure 57. Australia Paclitaxel Injection Revenue Growth 2016-2021 ($ Millions)
Figure 58. Europe Paclitaxel Injection Sales Market Share by Country in 2020
Figure 59. Europe Paclitaxel Injection Revenue Market Share by Country in 2020
Figure 60. Europe Paclitaxel Injection Sales Market Share by Type in 2020
Figure 61. Europe Paclitaxel Injection Sales Market Share by Application in 2020
Figure 62. Germany Paclitaxel Injection Revenue Growth 2016-2021 ($ Millions)
Figure 63. France Paclitaxel Injection Revenue Growth 2016-2021 ($ Millions)
Figure 64. UK Paclitaxel Injection Revenue Growth 2016-2021 ($ Millions)
Figure 65. Italy Paclitaxel Injection Revenue Growth 2016-2021 ($ Millions)
Figure 66. Russia Paclitaxel Injection Revenue Growth 2016-2021 ($ Millions)
Figure 67. Middle East & Africa Paclitaxel Injection Sales Market Share by Country in 2020
Figure 68. Middle East & Africa Paclitaxel Injection Revenue Market Share by Country in 2020
Figure 69. Middle East & Africa Paclitaxel Injection Sales Market Share by Type in 2020
Figure 70. Middle East & Africa Paclitaxel Injection Sales Market Share by Application in 2020
Figure 71. Egypt Paclitaxel Injection Revenue Growth 2016-2021 ($ Millions)
Figure 72. South Africa Paclitaxel Injection Revenue Growth 2016-2021 ($ Millions)
Figure 73. Israel Paclitaxel Injection Revenue Growth 2016-2021 ($ Millions)
Figure 74. Turkey Paclitaxel Injection Revenue Growth 2016-2021 ($ Millions)
Figure 75. GCC Country Paclitaxel Injection Revenue Growth 2016-2021 ($ Millions)
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles

※본 조사보고서 [세계의 파클리탁셀 주사 시장예측 2021년-2026년] (코드 : LPI-2201K02130) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 파클리탁셀 주사 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 단백질 결합 파클리탁셀 (아브락산) 시장예측 2021년-2026년
LPI-2201K03297 / LP Information / 2021년 12월 / 본 조사보고서는 단백질 결합 파클리탁셀 (아브락산)의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Protein Bound Paclitaxel (Abraxane) will have significant change from previous year. By the most conservative estimates of global Protein Bound Paclitaxel (Abraxane) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 이소판인슐린 주사 시장예측 2021년-2026년
LPI-2201K00076 / LP Information / 2021년 12월 / 본 조사보고서는 이소판인슐린 주사의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Isophane Insulin Injection will have significant change from previous year. By the most conservative estimates of global Isophane Insulin Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 점성 보충 주사 시장예측 2021년-2026년
LPI-2201K02215 / LP Information / 2021년 12월 / 본 조사보고서는 점성 보충 주사의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Viscosupplementation Injection will have significant change from previous year. By the most conservative estimates of global Viscosupplementation Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 1115.1 million in 2020. Over...

세계의 히알루론산 (나트륨+주사) 시장예측 2021년-2026년
LPI-2201K00049 / LP Information / 2021년 12월 / 본 조사보고서는 히알루론산 (나트륨+주사)의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Hyaluronic Acid (Sodium +Injection) will have significant change from previous year. By the most conservative estimates of global Hyaluronic Acid (Sodium +Injection) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 6748.9...

세계의 수의학용 주사 바늘 시장예측 2021년-2026년
LPI-2201K02696 / LP Information / 2021년 12월 / 본 조사보고서는 수의학용 주사 바늘의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Veterinary Injection Needles will have significant change from previous year. By the most conservative estimates of global Veterinary Injection Needles market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 피하 주사용 일회용 펜 바늘 시장예측 2021년-2026년
LPI-2201K02580 / LP Information / 2021년 12월 / 본 조사보고서는 피하 주사용 일회용 펜 바늘의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일,...According to this latest study, the 2021 growth of Single-Use Pen Needles for Subcutaneous Injection will have significant change from previous year. By the most conservative estimates of global Single-Use Pen Needles for Subcutaneous Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in...